MEDIGENE AG NA O.N./ DE000A1X3W00 /
2/2/2023 3:36:14 PM | Chg. +0.02 | Volume | Bid3:36:27 PM | Ask3:36:27 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.11EUR | +0.96% | 22,027 Turnover: 46,344.89 |
2.08Bid Size: 1,500 | 2.11Ask Size: 1,400 | 50.6 mill.EUR | 0.00% | - |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -0.41 EUR | -65.25% |
EPS Diluted: | -0.41 EUR | -65.25% |
Revenues per Share: | 0.43 EUR | 31.25% |
Book Value per Share: | 1.82 EUR | -15.79% |
Cash Flow per Share: | -0.44 EUR | -56.45% |
Dividend per Share: | 0.00 EUR | - |
Total | in mill. | |
Revenues: | 10.50 EUR | 31.25% |
Net Income: | -10.00 EUR | -65.40% |
Operating Cash Flow: | -10.80 EUR | - |
Cash and Cash Equivalents: | 22.40 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 4.82 | 6.71 |
P/BV ratio: | 1.13 | 1.57 |
P/CF Ratio: | -4.69 | -6.53 |
PEG: | 0.08 | - |
Earnings Yield: | -19.90% | -14.29% |
Dividend Yield: | 0.00% | 0.00% |
Market Capitalization | ||
Market Capitalization: | 50.6 mill. EUR | 70.5 mill. EUR |
Free Float Market Cap.: | 43.26 mill. EUR | 60.27 mill. EUR |
Market Cap. / Employee: | 790,621.5625 EUR | 1.1 mill. EUR |
Shares Outstanding: | 24.56 mill. |
Profitability
Gross Profit Margin: | 3.95% |
EBIT Margin: | -95.24% |
Net Profit Margin: | -95.24% |
Return on Equity: | -22.32% |
Return on Assets: | -16.81% |
Financial Strength
Liquidity I / Cash Ratio: | 280.00% |
Liquidity II / Quick Ratio: | 280.00% |
Liquidity III / Current Ratio: | 302.50% |
Debt / Equity Ratio: | 32.81% |
Dynam. Debt / Equity Ratio: | -136.11% |
Efficiency
Employees: | 64 |
Personal Expenses / Employee: | 135,703.13 EUR |
Revenues / Employee: | 164,062.50 EUR |
Net Income / Employee: | -156,250.00 EUR |
Total Assets / Employee: | 929,687.50 EUR |
* Fiscal Year End: | 12/31/2021 |
Accounting Standard: | IFRS |
Currency: | EUR |